Company type | Public company |
---|---|
Nasdaq: NOTV | |
Industry | Pharmaceutical industry |
Founded | 1974 | as Bioanalytical Systems
Founder | Peter Kissinger |
Headquarters | Lafayette, Indiana, United States |
Key people | |
Services | Contract research organization |
Revenue |
|
| |
| |
Total assets |
|
Total equity |
|
Number of employees | 1,200+ (2020) |
Website | www |
Footnotes / references [1] |
Animal testing |
---|
Main articles |
Testing on |
Issues |
Cases |
Companies |
Groups/campaigns |
|
Writers/activists |
Categories |
Inotiv, Inc. is a contract research organization organized in Indiana and headquartered in Lafayette, Indiana. The company operates two core business units: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The CRS business unit offers drug development and environmental sciences services, including safety assessment, analytical, metabolism, CMC and regulatory consultancy for small molecule drug candidates, biotherapeutics, and biomedical devices. The RMS business unit provides research models (live animals), lab animal diets and bedding and support services.[1]
The company has been criticized for its animal testing practices, most specifically animal testing on non-human primates as well as on beagles. It has also been criticized for its laboratory animal sources. In 2022, the United States Department of Agriculture found multiple violations of the Animal Welfare Act of 1966 at the company's dog-breeding facility in Cumberland, Virginia, to which the company plead guilty, resulting in $35 million in fines. The company is accredited by AAALAC International.[2]